ResMed Revenue

In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.

Revenue

5.15B

Revenue Growth

+9.84%

P/S Ratio

8.20

Revenue / Employee

485.50K

Employees

10,600

Market Cap

42.21B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	5.15B	461.03M	9.84%
Jun 30, 2024	4.69B	462.30M	10.95%
Jun 30, 2023	4.22B	644.87M	18.02%
Jun 30, 2022	3.58B	381.30M	11.93%
Jun 30, 2021	3.20B	239.81M	8.11%
Jun 30, 2020	Pro	Pro	Pro
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Veradigm	588.02M
Tian'an Technology Group	1.78M
Elite Pharmaceuticals	84.04M
Glass House Brands	215.62M
American Oncology Network	1.76B
Northwest Biotherapeutics	1.47M
Silence Therapeutics	27.17M
Global Cord Blood	196.10M

Revenue Rankings

ResMed News

6 days ago - How Resmed’s Mick Farrell turned a $7b company into a $62b giant - The Australian Financial Review
7 days ago - Top 50 High-Quality Dividend Stocks For August 2025 - Seeking Alpha
9 days ago - ResMed RMD Q4 2025 Earnings Call Transcript - The Motley Fool
9 days ago - Nasdaq 100 and S&P500: Tech and Healthcare Stocks Lead US Indices Higher Today - FX Empire
12 days ago - ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings - Benzinga
12 days ago - ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings - Benzinga
13 days ago - ResMed declares $0.60 dividend - Seeking Alpha
13 days ago - ResMed (RMD) Reports Strong Q4 2025 Results, Announces Dividend Increase - GuruFocus

More News